pharmaphorum

NOVEMBER 20, 2022

In addition, it offered the opportunity for new solutions and approaches to many of today’s healthcare challenges. Without sacrificing on the robust science of R&D, teams were able to accelerate overall development schedules by removing lags in clinical trial phase timelines.

Vaccination 90

Vaccination Vaccine Development Clinical Development 90

XTalks

NOVEMBER 1, 2023

The revolution in clinical research is here, and it’s embodied by a single, powerful word: “patients.” The inclusion of patients during clinical development is not only a moral imperative but a strategic necessity in modern medical research.

Clinical Trials 87

Clinical Trials Clinical Trials Trials Clinical Development 87

XTalks

MARCH 5, 2021

The acquisition will see ICON plc, global provider of development and commercialization services to the pharmaceutical, biotechnology and medical device industries, expand its portfolio to leverage PRA’s mobile and connected health platforms, along with its data and information solutions. Accelerating Development.

Development 98

Development Trials Clinical Development Medicine 98

Drug Discovery World

FEBRUARY 12, 2024

Updesh Dosanjh, Practice Leader for Pharmacovigilance Technology Solutions, IQVIA “In 2024, the traditional pain points of the pharmacovigilance (PV) space will not disappear. It’s no surprise that interest in AI for this area is surging, since early phase drug discovery normally accounts for 42% of the cost of the entire pipeline.

Genome 139

Genome Genomics Life Science Gene Therapy 139

pharmaphorum

JANUARY 14, 2022

In the latest episode of the pharmaphorum podcast, Dr Paul Tunnah speaks to head of Patient Engagement at Syneos Health, Marie Emms, and Elligo executive vice president and general manager of Worldwide Clinical Trials Early Phase Services, Keith Fern. About Syneos Health.

Clinical Trials 90

Clinical Trials Clinical Trials Trials Compliance 90

Drug Discovery World

AUGUST 7, 2023

In our current environment of political polarization, efforts to encourage diversity are unable to prevail, and more needs to be done to foster the trust that is necessary for broader participation in clinical trial recruitment. RA: How does a lack of patient diversity in trials impact how treatments work in certain populations?

Development 98

Development Clinical Trials Clinical Trials Drugs 98

XTalks

JUNE 14, 2023

Novaliq, a biopharmaceutical company specializing in ocular therapeutics, recently announced that their product Vevye (cyclosporine ophthalmic solution) 0.1 Vevye is the first and sole cyclosporine solution specifically prescribed for addressing the signs and symptoms of dry eye disease with efficacy validated after four weeks of treatment.

Gene Silencing 97

Gene Silencing Drug Delivery FDA Approval RNA 97

Velocity Clinical Research

OCTOBER 4, 2023

Traditionally, clinical trials in the U.K. have been dominated by the NHS and University-based research, but with funding pressures and the continuing toll of COVID on these institutions, we believe private organisations like Velocity are an alternative solution to deliver faster start up, greater efficiency, and quicker data delivery.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

Pharmaceutical Technology

JUNE 15, 2023

The power of modern AI can help organizations find solutions faster, optimize their operations and enable innovation. Product management AI in product management can improve every phase of a product, from ideation to development to commercialization. How is AI used in the pharmaceutical industry?

Pharma R&D 130

Pharma R&D Production Manufacturing Development 130

XTalks

MAY 19, 2023

And don’t forget to explore the upcoming webinars about clinical trials on Xtalks to see what piques your curiosity about the latest clinical trial solutions. Increasing Number of Registered Clinical Trials As of May 17, 2023, there are 452,604 registered clinical trials globally on ClinicalTrials.gov. percent, 81.1

Clinical Trials 97

Clinical Trials Clinical Trials Trials Clinical Research 97

XTalks

JANUARY 17, 2024

Additionally, Dr. Morrison mentioned that different types of data are being applied in the clinical development space, including the increasing focus and importance of real-world evidence to support clinical data and early registration of assets where there is a significant unmet need.

Clinical Trials 124

Clinical Trials Clinical Trials Trials Gene Therapy 124

XTalks

OCTOBER 12, 2022

However, the role of MRI in new drug clinical trials can involve diagnosis of lesions and determination of their severity, early identification of therapeutic responders to drug treatment and treatment monitoring and follow-up. For most of this time, MRI mainly was used for qualitative interpretation and simple structural measurements.

Clinical Trials 93

Clinical Trials Clinical Trials Trials Drugs 93

The Pharma Data

OCTOBER 29, 2020

Biotechs get scalable early to late phase clinical offering from Cromos Pharma and Avance Clinical collaboration in Australia and Europe. on clinical trial costs, throughout all study phases, across both regions. on clinical trial costs, throughout all study phases, across both regions. “We

Clinical Trials 40

Clinical Trials Clinical Trials Trials Clinical Research 40

Worldwide Clinical Trials

JUNE 15, 2022

Early engagement and discussions can help you prevent the risk of a clinical hold. To discuss your study and how to reduce the chances of receiving a clinical hold, talk with us. . It really is—there has been a 10x increase in cell and gene therapies in the clinical development pipeline since 2012.

Gene Therapy 130

Gene Therapy Gene Clinical Trials Clinical Trials 130

The Pharma Data

JULY 29, 2021

Eisai and Biogen Present Preliminary Assessment of the Clinical Effects of Lecanemab Following 18 Months of Treatment in the Open-Label Extension of the Phase 2 Proof of Concept Study at 2021 Alzheimer’s Association International Conference (AAIC) . United States and virtually from July 26 to 30, 2021 (Presentation No.:

Clinical Trials 52

Clinical Trials Clinical Trials Development Antibody 52

Drug Discovery World

SEPTEMBER 12, 2022

We are hopefully nearing the tail-end of a pandemic that made the whole world become participants in that deep learning experience of what clinical development is. I think never before did we have families sit on the couch and talk about Phase I, II and III clinical trials.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Gene Therapy 52

pharmaphorum

JUNE 24, 2022

It is still working on new drug therapies, including BTK inhibitor obelabrutinib in phase 2, a follow-up (BIIB091) in phase 1 and anti-VLA4 drug BIIB107, also in early clinical development. ” The post Biogen and Happify partner on digital support for MS patients appeared first on.

Pharma Companies 40

Pharma Companies Development Clinical Development Marketing 40

The Pharma Data

OCTOBER 6, 2021

Early-stage research suggests potential to prevent and treat all dengue serotypes With no treatments available, dengue infects up to 400 million people each year and the pace of outbreaks is increasing. [1] Janssen is now moving its dengue program into clinical development. Janssen Pharmaceutica, N.V.

Clinical Development 52

Clinical Development Development Research Licensing 52

Drug Discovery World

JANUARY 17, 2024

With oncology accounting for a third of pharma’s product pipeline, significant challenges include fierce competition, high research and development costs over, 10-15 years for clinical development, and pressures to rapidly meet the demand for new treatments 2-4.

Medicine 59

Medicine DNA Genome Genomics 59

The Pharma Data

JULY 23, 2021

(Nasdaq: BIIB) today announced it will share multiple oral and poster presentations from its Alzheimer’s disease clinical development portfolio at the Alzheimer’s Association International Conference (AAIC), which will be held in Denver, Colorado and online July 26-30, 2021.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Development 52

The Pharma Data

JANUARY 24, 2021

25, 2021 /PRNewswire/ — Therapeutic Solutions International, Inc., (OTC Technologies developed by Therapeutic Solutions International allow for the manufacture of unique dendritic cells from cord blood stem cells, which can be used in a universal donor manner. . OCEANSIDE, Calif., Source link.

Marketing 52

Marketing Development Business Development Drugs 52

pharmaphorum

APRIL 15, 2021

As these innovations – which have the potential to be transformative for patients – enter uncharted regulatory territory, the pathway is not always clear or well-defined, which is why Astellas adopts a proactive approach to early communication with health authorities. “We A strategic partner.

Development 61

Development Manufacturing Production Bioinformatics 61

XTalks

JANUARY 6, 2021

Mind Medicine was the first psychedelic firm to make a public debut on Toronto’s NEO Exchange in early 2020. Rather than substituting one addictive substance for another less-harmful one, they are developing a drug that treats the cause of the brain disease which is addiction. Mind Medicine. Champignon Brands.

Drugs 97

Drugs Clinical Trials Clinical Trials Medicine 97

Drug Discovery World

MAY 16, 2023

Many developers encounter multi-year delays in programme development because they fail to invest in the development of later stage processes critical to scale-up while collecting early clinical data. The solution?

Gene Therapy 52

Gene Therapy Gene Manufacturing Marketing 52

XTalks

JULY 3, 2023

The US Food and Drug Administration (FDA) has given its approval to Suflave, a colonoscopy preparation product developed by Braintree Laboratories, a division of Sebela Pharmaceuticals. It is noteworthy for its lemon-lime flavor, which likens it to a sports drink. How Can Suflave Boost Patient Compliance?

FDA Approval 97

FDA Approval Compliance Clinical Trials Clinical Trials 97

XTalks

SEPTEMBER 5, 2023

Xtalks spoke with Maria Reyes Boceta-Muñoz, Clinical Operations Head of Development R&D at GlaxoSmithKline in Spain, Portugal & Israel, to understand the current vaccine development climate and where the sector is headed. What are the major challenges you’re facing right now in vaccine development?

Vaccination 96

Vaccination Vaccine Development Clinical Trials 96

The Pharma Data

MARCH 8, 2021

The companies today reported findings on one secondary objective from the Phase 2a study, showing a reduction in time (days) to negativity of infectious virus isolation in nasopharyngeal swabs from participants with symptomatic SARS-CoV-2 infection, as determined by isolation in Vero cell line culture. This press release features multimedia.

Trials 69

Trials In-Vivo Genotoxicity RNA 69

The Pharma Data

SEPTEMBER 16, 2020

New and updated data from across our broad cancer portfolio including phase III results in breast, lung and prostate cancers. New integrated analyses from our tumour agnostic Rozlytrek ® (entrectinib) clinical development programme. Sign up here for the session on Saturday, 19 September, 16:00-16:30 CEST.

HR 52

HR Medicine Hormones Trials 52

Drug Discovery World

MARCH 7, 2023

Powers taught for more than six years at the National Institutes of Health, on medical product development and commercialisation, and at Georgetown Law School as an adjunct professor. Dr Janette Thomas, CEO, Five Alarm Bio Five Alarm Bio is an anti-ageing therapeutics company, which completed a seed investment round in early 2023.

Life Science 98

Life Science DNA Clinical Development Development 98

Delveinsight

AUGUST 25, 2021

The J&J key focus areas in medical devices include Orthopaedic, Surgery, Interventional Solutions (cardiovascular and neurovascular), and Eye Health. billion), and Interventional Solutions (USD 3 billion). Roche is the second-biggest spender on research and development, with an investment of USD 13 billion in the year 2020.

Vaccination 98

Vaccination Vaccine Sales Drugs 98

The Pharma Data

MARCH 26, 2021

The FDA EUA submission is based on an interim analysis of efficacy and safety data from the Phase 3 COMET-ICE (COVID-19 Monoclonal antibody Efficacy Trial – Intent to Care Early) trial, which evaluated VIR-7831 as monotherapy for the early treatment of COVID-19 in adults at high risk of hospitalisation.

Antibody 52

Antibody Trials Vaccination Vaccine 52

The Pharma Data

JANUARY 21, 2021

Before that, Doyle was Director of Business Unit Financial Planning & Analysis, Early Phase Division, at PAREXEL. CHF Solutions – Nestor Jaramillo was named president and CEO of Minnesota-based CHF Solutions. Prior to joining CHF Solutions, Jaramillo was president and CEO of Innerspace Neuro Solutions, Inc.

Medicine 52

Medicine Development Engineer Production 52

XTalks

NOVEMBER 6, 2020

Canadian clinical-stage biotech company Symvivo Corporation has developed an oral COVID-19 vaccine that entered clinical trials this week. The first healthy volunteer was dosed with the vaccine in Australia as part of the bacTRL-Spike COVID-19 Phase I clinical trial. COVID-19 Clinical Trials.

Clinical Trials 75

Clinical Trials Clinical Trials Vaccination Vaccine 75

Drug Discovery World

MARCH 6, 2024

To do otherwise risks missing novel targets or overfocusing on the most obvious GWAS (Genome Wide Association Studies) associations, such as that linking the APOε4 gene to Alzheimer’s, in the expectation that we can force a ‘one-drug-fits-all’ solution.

Genome 64

Genome Genomics Clinical Trials Clinical Trials 64

The Pharma Data

DECEMBER 23, 2020

24, 2020 /PRNewswire/ — COVAXX’s UB-612 is the first multitope, synthetic peptide-based COVID-19 vaccine candidate in clinical trials and it utilizes normal refrigeration (no freezing required) for distribution. COVAXX is currently conducting a Phase 1 clinical trial for the vaccine candidate. .

Vaccination 52

Vaccination Vaccine Development Manufacturing 52

The Pharma Data

SEPTEMBER 8, 2021

Amgen (NASDAQ: AMGN) today announced results from two analyses of the Phase 2 CodeBreaK 100 clinical trial evaluating LUMAKRAS™ (sotorasib), the first and only KRAS G12C inhibitor approved in the U.S., ” New Analyses From the LUMAKRAS Phase 2 CodeBreaK 100 Clinical Trial. In the U.S., About CodeBreaK.

Trials 52

Trials Clinical Trials Clinical Trials Clinical Development 52

WCG Clinical

JULY 17, 2023

Listen in as we discuss the results of WCG’s recently published 2023 Clinical Research Site Challenges Survey Report , gain insights from our guests on solutions their organizations have implemented to reduce site burden, and share perspectives on how sites, sponsors, and CROs can work to improve site and trial efficiency.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Research 52